Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check18 days agoChange DetectedThe page has been updated to include new information about metastatic non-small cell lung cancer and a new version revision, while significant details about a Phase 3 study and its criteria have been removed.SummaryDifference3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 22, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check41 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.14.3) and a new date for the results first posted, changing from January 22, 2025, to March 25, 2025.SummaryDifference0.2%
- Check106 days agoChange DetectedThe study has expanded to include 343 locations across various states and countries, with new results expected to be posted on January 22, 2025, while previous results and locations have been removed.SummaryDifference99%
- Check113 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.